INT56148
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
We found a significant enhancement of interferon-gamma (IFN-gamma) and soluble interleukin-2 receptor (sIL-2R) release in lipopolysaccharide (LPS)-stimulated whole blood cultures after induction of anesthesia. | |||||||||||||||
| |||||||||||||||
|
When activated, lymphocytes secrete glycoproteins related to particular surface proteins, including soluble forms of the interleukin-2 receptor (sIL-2R) and of the surface proteins CD4 (sCD4) and CD8 (sCD8). | |||||||||||||||
| |||||||||||||||
|
secreting CD8+ clones specific for gp100 and Melan A/MART-1 even before vaccination, and this high frequency did not change (gp100) or slightly decreased (Melan A/MART-1) after vaccination. | |||||||||||||||
| |||||||||||||||
|
For gp100, frequencies of 70 × 10-5 and 35 × 10-5 CD8+ T cells secreting IFN-? | |||||||||||||||
| |||||||||||||||
|
i) For five patients enough PBMC were obtained before and 14 days after the fourth vaccination to analyze the presence of gp100 and Melan A/MART-1 specific CD8+T cells by tetramer staining. | |||||||||||||||
| |||||||||||||||
|
To avoid this, Ethics Committees in certain countries (Austria, Denmark and Germany) specified that consent must be obtained after surgery, in order to prove that surgeons' were not influenced in their decision to use TachoSil. | |||||||||||||||
| |||||||||||||||
|
This prospective, non-interventional European surveillance study, conducted in a real-world clinical setting, suggests that patients undergoing surgery who receive TachoSil are not at increased risk of TEEs, major bleeding or immunological events. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.